ISPE announced Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo, taking place 27–30 October 2019 in Las Vegas, Nevada USA.
Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data expert and clinical researcher. She helps oversee the FDA’s day-to-day functioning and directs special and high-priority initiatives that cut across offices overseeing the agency's regulation of drugs, medical devices, tobacco, and food. As acting Chief Information Officer, she oversees FDA’s data and technical vision, and its execution.
In a “fireside chat” with Frances Zipp, President & CEO, Lachman Consultant Services, Inc., incoming 2019–2020 ISPE Board Chair, Dr. Abernethy will be answering key questions regarding current FDA initiatives.
Dr. Abernethy joins a dynamic keynote line-up that includes some of the most prominent names in the pharmaceutical industry. These senior-level presentations are rounded out by a compelling patient keynote speaker.
Training Tomorrow’s Workforce
When Drug Research is Personal: A Lifetime Journey to Discover, Create and Manufacture Medicines for Rare Diseases
Every Patient Matters — Transforming to Deliver Breakthroughs Faster
Transforming Big Pharma Manufacturing: Dream or Reality?
How to Achieve Industrialization and Bring Curative Therapies to the Masses
Thriving in My New Normal